Physician profile
Sameen Nooruddin
NPI 1568825693
$1,779.11
in general payments reported to CMS, 2019-2025
27 companies · $161 in 2025
The $161 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $72.33 · 2021: $373 · 2022: $404 · 2023: $431 · 2024: $337 · 2025: $161.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $929.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $929.26 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $429.38 | 2020-2024 | |
| Exeltis, USA INC. | $151.43 | 2022-2025 | Slynd, Nuvessa |
| Sumitomo Pharma America, INC. | $142.43 | 2023-2024 | Myfembree |
| Myovant Sciences INC. | $132.88 | 2021-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $107.82 | 2021-2023 | |
| Hologic Sales and Service, LLC | $83.72 | 2023-2025 | Novasure, Fluent Fluid Management System, Acessa Provu System |
| Caldera Medical, INC | $81.13 | 2023 | Desara |
| Agile Therapeutics, INC. | $64.17 | 2022-2023 | Twirla |
| Organon LLC | $63.20 | 2021-2023 | Nexplanon |
| Aspira Women'S Health INC | $62.55 | 2022-2024 | Ova1 |
| Mayne Pharma Commercial LLC | $55.41 | 2022-2024 | |
| Pfizer INC. | $40.48 | 2024 | |
| Merck Sharp & Dohme LLC | $33.93 | 2021 | |
| Exact Sciences Corporation | $32.66 | 2023-2024 | Cologuard Collection Kit |
| Coopersurgical, INC. | $32.39 | 2021-2022 |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $32.30 | 2023-2024 | Evenity, Prolia |
| Smith+Nephew, INC. | $28.60 | 2024 | Pico 7 |
| Astellas Pharma US INC | $27.16 | 2025 | Veozah |
| Evofem Biosciences, INC. | $24.00 | 2020 | |
| Axonics, INC. | $23.65 | 2024 | Axonics |
| Novo Nordisk INC | $23.27 | 2023 | Wegovy |
| Medtronic, INC. | $22.27 | 2023 | V-Loc 180 |
| Sage Therapeutics, LLC | $20.45 | 2025 | Zurzuvae |
| Medicem INC. | $17.05 | 2021 | |
| Shield Therapeutics INC | $16.83 | 2022 | |
| Scynexis, INC. | $15.11 | 2022 | |
| Amneal Pharmaceuticals LLC | $14.84 | 2025 | Unithroid |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sameen Nooruddin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.